Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Booster”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05664932
What this trial is testing

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 1,200
Large-scale testing (Phase 3)Ended earlyNCT04904549
What this trial is testing

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

Who this might be right for
COVID-19
Sanofi Pasteur, a Sanofi Company 23,670
Early research (Phase 1)Study completedNCT05477186
What this trial is testing

Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Who this might be right for
COVID-19SARS-CoV-2
GlaxoSmithKline 185
Large-scale testing (Phase 3)Study completedNCT05299359
What this trial is testing

A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Coronavirus Disease (COVID-19)
Takeda 150
Large-scale testing (Phase 3)Ended earlyNCT05047640
What this trial is testing

COVID-19 3rd Dose Vaccine in Transplant Patients

Who this might be right for
Covid19
Giselle Guerra 58
Testing effectiveness (Phase 2)UnknownNCT05124483
What this trial is testing

Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study)

Who this might be right for
COVID-19
University Medical Center Groningen 600
Large-scale testing (Phase 3)Study completedNCT05096832
What this trial is testing

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 10,381
Large-scale testing (Phase 3)WithdrawnNCT05442684
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine

Who this might be right for
COVID-19
CanSino Biologics Inc.
Large-scale testing (Phase 3)Study completedNCT05463419
What this trial is testing

A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose.

Who this might be right for
Covid-19 Vaccine
Yisheng Biopharma (Singapore) Pte. Ltd. 5,860
Not applicableStudy completedNCT05586178
What this trial is testing

Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake

Who this might be right for
COVID-19Vaccines
University of California, Los Angeles 177,720
Post-approval studies (Phase 4)UnknownNCT05104333
What this trial is testing

Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes

Who this might be right for
COVID-19 Pneumonia
China National Biotec Group Company Limited 1,440
Not applicableStudy completedNCT06575114
What this trial is testing

COVID-19 Vaccination Willingness in Older Adults Based on Self-determination Theory

Who this might be right for
Old Age; DebilityVaccine HesitancyVaccine Refusal
Jing-Shan Deng 264
Not applicableUnknownNCT05483725
What this trial is testing

Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

Who this might be right for
Kidney DiseasesKidney Transplant; ComplicationsCOVID-19+3 more
Institute for Clinical and Experimental Medicine 108
Large-scale testing (Phase 3)Ended earlyNCT05228730
What this trial is testing

Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).

Who this might be right for
COVID-19
Murdoch Childrens Research Institute 13
Large-scale testing (Phase 3)WithdrawnNCT05387317
What this trial is testing

Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)

Who this might be right for
COVID-19
Murdoch Childrens Research Institute
Testing effectiveness (Phase 2)Study completedNCT05160766
What this trial is testing

Assessing Immune Response of Different COVID-19 Vaccines in Older Adults

Who this might be right for
Prevention of COVID-19
Oliver Cornely, MD 323
Large-scale testing (Phase 3)Study completedNCT05354024
What this trial is testing

Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine

Who this might be right for
Coronavirus InfectionsHealthy
Butantan Institute 4,400
Not applicableUnknownNCT05367895
What this trial is testing

Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 14,000
Not applicableUnknownNCT05087277
What this trial is testing

Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain

Who this might be right for
COVID-19
Centers for Disease Control and Prevention, China 150
Testing effectiveness (Phase 2)UnknownNCT05172193
What this trial is testing

Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)

Who this might be right for
COVID-19
PT. Kimia Farma (Persero) Tbk 600
Next Page